Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO): Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO): primary endpoint results, effect estimate with confidence interval, sample-size…
- Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty: primary endpoint results, effect estimate with…
- Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA): Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety and Efficacy Study of Hydromorphone Hydrochloride by Intrathecal Administration: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Hydromorphone Hydrochloride by Intrathecal Administration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01709721).
- Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety and Efficacy Study of MK0974 in the Acute Migraine (0974-016): Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of MK0974 in the Acute Migraine (0974-016): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety and Efficacy Study of MT-2990 in Women With Endometriosis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of MT-2990 in Women With Endometriosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03840993).
- Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD: primary endpoint results, effect estimate with confidence interval, sample-size…
- Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With…
- Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006): Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung…
- Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities: primary endpoint results, effect estimate with confidence interval,…
- Safety and Efficacy Study of PLX3397 in Adults With Relapsed or Refractory Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of PLX3397 in Adults With Relapsed or Refractory Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Safety and Efficacy Study of Ramelteon in Subjects With Chronic Insomnia: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Ramelteon in Subjects With Chronic Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size…
- Safety and Efficacy Study of Several Replagal Dosing Regimens on Cardiac Function in Adults With Fabry Disease: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Several Replagal Dosing Regimens on Cardiac Function in Adults With Fabry Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone: primary endpoint results, effect estimate with confidence…
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic…
- Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing Myopathy: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing Myopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal Candidiasis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal Candidiasis: primary endpoint results, effect estimate…
- Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD): Complete Statistical AnalysisIndependent statistical analysis of Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer: Complete Statistical AnalysisIndependent statistical analysis of Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine: primary endpoint results, effect…
- Safety and Immunogenicity of a First-in-Human Mosquito Saliva Peptide Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Safety and Immunogenicity of a First-in-Human Mosquito Saliva Peptide Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03055000).
- Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women: Complete Statistical AnalysisIndependent statistical analysis of Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years): Complete Statistical AnalysisIndependent statistical analysis of Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years): primary endpoint results, effect estimate with confidence interval, sample-size…
- Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults: Complete Statistical AnalysisIndependent statistical analysis of Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR): Complete Statistical AnalysisIndependent statistical analysis of Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02445963).
- Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®: Complete Statistical AnalysisIndependent statistical analysis of Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®: primary endpoint results, effect estimate with…
- Safety and Immunogenicity of Different Schedules of Takeda’s Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults: Complete Statistical AnalysisIndependent statistical analysis of Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Immunogenicity of GSK Biologicals’ HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old: Complete Statistical AnalysisIndependent statistical analysis of Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old: primary endpoint results, effect estimate with confidence interval, sample-size…
- Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals’ DTPa-HBV-IPV/Hib Vaccine (GSK217744): Complete Statistical AnalysisIndependent statistical analysis of Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects.: Complete Statistical AnalysisIndependent statistical analysis of Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects.: primary endpoint results, effect estimate with confidence interval, sample-size…